ZEVRA THERAPEUTICS, INC. (ZVRA) › Operating IncomeZEVRA THERAPEUTICS, INC. (ZVRA) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2013: -$4.72M2014: -$16.44M2015: -$22.81M2016: -$37.48M2017: -$33.37M2018: -$55.90M2019: -$20.34M2020: -$5.61M2021: $7.73M2022: -$42.56M2023: -$49.60M2024: -$87.00M2025: -$62.94M-$62.94M2013Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$62.94M+27.7%2024-$87.00M-75.4%2023-$49.60M-16.5%2022-$42.56M-650.7%2021$7.73M+237.8%2020-$5.61M+72.4%2019-$20.34M+63.6%2018-$55.90M-67.5%2017-$33.37M+11.0%2016-$37.48M-64.3%2015-$22.81M-38.7%2014-$16.44M-248.5%2013-$4.72M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share